Who is sponsoring NCT03520127?

NCT03520127 is sponsored by Medtronic Surgical Technologies.

What drugs are being tested in NCT03520127?

Interventions in NCT03520127: Intact Breast Lesion Excision System (BLES).

What condition does NCT03520127 study?

NCT03520127 studies Breast Lesions.

Is NCT03520127 still recruiting?

NCT03520127 is currently terminated. Last updated 16 May 2019.

Last reviewed 2019-05-16 · How we verify

NCT03520127

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

Terminated Last updated 16 May 2019

What this trial tests

trial testing Intact Breast Lesion Excision System (BLES) in Breast Lesions in 176 participants. Terminated before completion.

Timeline

27 September 2017

Primary endpoint
15 February 2019

28 February 2019

Quick facts

Lead sponsor	Medtronic Surgical Technologies
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	176
Start date	27 September 2017
Primary completion	15 February 2019
Estimated completion	28 February 2019
Sites	7 locations across United States

Drugs / interventions tested

Intact Breast Lesion Excision System (BLES)

Conditions studied

Breast Lesions — all drugs for Breast Lesions →

Sponsor

Medtronic Surgical Technologies

Who can join

18 and older, female only, with Breast Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this registry study is to collect use and clinical outcomes data following breast lesion excision or sampling with the Intact BLES.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Medtronic Surgical Technologies trials

Trials by the same sponsor.

NCT05747014 — Novapak Prospective Observational Clinical Trial · completed
NCT03143257 — Ambispective Clinical Evaluation of Sophono™ · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03520127 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic Surgical Technologies
Last refreshed: 16 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03520127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing